Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GeneDx Holdings Corp.CL A(WGS) | 3,507,164 | 3,507,164 | 0 | $269.56M | $310.61M | 25.38% | +$41.05M |
| Biolife Solutions Inc | 8,707,165 | 8,707,165 | 0 | $226.04M | $198.87M | 16.25% | -$27.17M |
| Revolution Medicines, Inc.(RVMD) | 3,699,283 | 3,697,933 | -1,350 | $161.81M | $130.76M | 10.68% | -$31.05M |
| Standard BioTools Inc.(LAB) | 71,254,677 | 76,075,636 | +4,820,959 | $124.70M | $82.16M | 6.71% | -$42.53M |
| Avidity Biosciences Inc | 2,045,000 | 2,045,000 | 0 | $59.47M | $60.37M | 4.93% | +$899.8K |
| Sarepta Therapeutics, Inc.(SRPT) | 1,073,500 | 900,783 | -172,717 | $130.53M | $57.49M | 4.70% | -$73.04M |
| Illumina, Inc.(ILMN) | 750,000 | 595,000 | -155,000 | $100.22M | $47.21M | 3.86% | -$53.02M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 140,000 | 120,000 | -20,000 | $32.94M | $32.40M | 2.65% | -$541.0K |
| Blueprint Medicines Corp | 326,378 | 326,378 | 0 | $28.47M | $28.89M | 2.36% | +$421.0K |
| Beam Therapeutics Inc.(BEAM) | 1,250,000 | 1,425,562 | +175,562 | $31.00M | $27.84M | 2.27% | -$3.16M |
| Relay Therapeutics, Inc.(RLAY) | 8,948,574 | 9,098,574 | +150,000 | $36.87M | $23.84M | 1.95% | -$13.03M |
| Codexis, Inc.(CDXS) | 8,100,000 | 8,100,000 | 0 | $38.64M | $21.79M | 1.78% | -$16.85M |
| Verve Therapeutics Inc | 3,995,571 | 3,995,571 | 0 | $22.54M | $18.26M | 1.49% | -$4.28M |
| Endeavour Silver Corp.(EXK) | 650,000 | 405,000 | -245,000 | $36.52M | $17.53M | 1.43% | -$18.99M |
| Neurogene Inc.(NGNE) | 1,295,361 | 1,295,361 | 0 | $29.61M | $15.17M | 1.24% | -$14.44M |
| Intellia Therapeutics, Inc.(NTLA) | 2,000,000 | 2,000,000 | 0 | $23.32M | $14.22M | 1.16% | -$9.10M |
| Denali Therapeutics Inc.(DNLI) | 990,000 | 990,000 | 0 | $20.18M | $13.46M | 1.10% | -$6.72M |
| Structure Therapeutics IncADS | 700,000 | 700,000 | 0 | $18.98M | $12.12M | 0.99% | -$6.87M |
| BeOne Medicines AGADS(ONC) | 0 | 40,000 | +40,000 | $0 | $10.89M | 0.89% | +$10.89M |
| Guardant Health, Inc.(GH) | 350,000 | 250,000 | -100,000 | $10.69M | $10.65M | 0.87% | -$42.5K |
| Maze Therapeutics, Inc.(MAZE) | 0 | 946,357 | +946,357 | $0 | $10.42M | 0.85% | +$10.42M |
| 2seventy Bio Inc | 2,000,000 | 2,000,000 | 0 | $5.88M | $9.88M | 0.81% | +$4.00M |
| Veracyte, Inc.(VCYT) | 276,308 | 276,308 | 0 | $10.94M | $8.19M | 0.67% | -$2.75M |
| GE HealthCare Technologies Inc.(GEHC) | 0 | 100,000 | +100,000 | $0 | $8.07M | 0.66% | +$8.07M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 475,000 | 635,000 | +160,000 | $6.28M | $7.80M | 0.64% | +$1.52M |
| Agios Pharmaceuticals, Inc.(AGIO) | 250,000 | 250,000 | 0 | $8.21M | $7.33M | 0.60% | -$890.0K |
| Moderna, Inc.(MRNA) | 175,000 | 225,000 | +50,000 | $7.28M | $6.38M | 0.52% | -$897.8K |
| Hims & Hers Health, Inc.CL A(HIMS) | 0 | 200,000 | +200,000 | $0 | $5.91M | 0.48% | +$5.91M |
| Tenaya Therapeutics, Inc.(TNYA) | 6,732,971 | 6,732,971 | 0 | $9.63M | $3.84M | 0.31% | -$5.79M |
| Verastem, Inc.(VSTM) | 0 | 600,000 | +600,000 | $0 | $3.62M | 0.30% | +$3.62M |
| Septerna, Inc.(SEPN) | 553,268 | 553,268 | 0 | $12.67M | $3.20M | 0.26% | -$9.47M |
| Solid Biosciences Inc | 0 | 775,000 | +775,000 | $0 | $2.87M | 0.23% | +$2.87M |
| Absci Corporation | 973,260 | 973,260 | 0 | $2.55M | $2.44M | 0.20% | -$107.1K |
| Teladoc Health, Inc.(TDOC) | 0 | 300,000 | +300,000 | $0 | $2.39M | 0.20% | +$2.39M |
| Century Therapeutics, Inc.(IPSC) | 5,190,506 | 3,212,316 | -1,978,190 | $5.24M | $1.53M | 0.12% | -$3.71M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 100,000 | +100,000 | $0 | $1.05M | 0.09% | +$1.05M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 296,666 | 148,333 | -148,333 | $4.35M | $1.04M | 0.08% | -$3.31M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 165,323 | 165,323 | 0 | $1.12M | $874.6K | 0.07% | -$243.0K |
| Pacific Biosciences of California, Inc.(PACB) | 1,035,859 | 723,767 | -312,092 | $1.90M | $854.0K | 0.07% | -$1.04M |
| Prime Medicine, Inc.(PRME) | 367,175 | 367,175 | 0 | $1.07M | $730.7K | 0.06% | -$341.5K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 86,014 | 86,014 | 0 | $596.9K | $399.1K | 0.03% | -$197.8K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 36,493 | 36,493 | 0 | $358.4K | $208.0K | 0.02% | -$150.4K |
| Tango Therapeutics, Inc.(TNGX) | 1,188,349 | 125,000 | -1,063,349 | $3.67M | $171.3K | 0.01% | -$3.50M |
| Kronos Bio Inc | 123,839 | 123,839 | 0 | $117.6K | $102.2K | 0.01% | -$15.5K |
| 4d Molecular Therapeutics In | 1,150,000 | 0 | -1,150,000 | $6.41M | $0 | — | -$6.41M |
| Fortrea Holdings Inc.(FTRE) | 275,000 | 0 | -275,000 | $5.13M | $0 | — | -$5.13M |